Holocene Advisors LP Acquires Shares of 15,227 HealthEquity, Inc. (NASDAQ:HQY)

Holocene Advisors LP purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 15,227 shares of the company's stock, valued at approximately $1,246,000.

A number of other institutional investors also recently modified their holdings of the business. Raymond James Trust N.A. lifted its stake in HealthEquity by 4.8% in the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock worth $238,000 after purchasing an additional 132 shares in the last quarter. Truist Financial Corp lifted its stake in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company's stock worth $247,000 after purchasing an additional 188 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in HealthEquity by 7.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company's stock worth $246,000 after purchasing an additional 198 shares in the last quarter. Elk River Wealth Management LLC lifted its stake in HealthEquity by 0.3% in the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company's stock worth $5,417,000 after purchasing an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC grew its holdings in shares of HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company's stock valued at $330,000 after purchasing an additional 233 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on HQY. BTIG Research increased their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a report on Thursday, November 14th. Barrington Research increased their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Monday, December 2nd. Bank of America increased their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday. They issued an "outperform" rating and a $126.00 price target on the stock. Finally, JMP Securities reissued a "market outperform" rating and issued a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $109.64.

HealthEquity Trading Down 0.6 %

Shares of NASDAQ:HQY traded down $0.64 on Friday, hitting $100.21. The company had a trading volume of 885,402 shares, compared to its average volume of 707,893. The firm's 50-day simple moving average is $92.42 and its two-hundred day simple moving average is $83.61. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $8.75 billion, a price-to-earnings ratio of 83.51, a P/E/G ratio of 1.61 and a beta of 0.55.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million during the quarter, compared to analysts' expectations of $284.48 million. Equities analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares of the company's stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now directly owns 4,823 shares of the company's stock, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock valued at $884,517 in the last three months. Company insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.